“Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic” (2023) Brazilian Journal of Pharmaceutical Sciences, 59, p. e21067. doi:10.1590/s2175-97902023e21067.